Back to 
Barclays plc
Barclays plc
ACRS
Showing 8 of 30 quarters
Position history for Barclays plc's holdings in Aclaris Therapeutics, Inc.
Yes. Barclays holds 73,010 shares of ACRS (Aclaris Therapeutics), worth $386,223, as of its Q2 2026 13F filing. It increased the position from 21,508 shares in Q1 2026. Barclays has held ACRS since Q1 2019, across 30 quarterly 13F filings.
Current Value
$386,223
Current Shares
73,010
Total Value Change
+$362,771
Total Shares Change
+52,617
Quarter-by-Quarter History
Other major holders of ACRS: Wellington Management Group LLP, Adage Capital Partners GP, L.L.C.